Prev：Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.(PRP1049-3)
Next：Engineering customized viral receptors for various coronaviruses.(ABT2230-)
